Edition:
United States

Viveve Medical Inc (VIVE.OQ)

VIVE.OQ on NASDAQ Stock Exchange Capital Market

5.14USD
2:03pm EST
Change (% chg)

$0.05 (+0.88%)
Prev Close
$5.10
Open
$5.10
Day's High
$5.23
Day's Low
$5.06
Volume
13,985
Avg. Vol
42,040
52-wk High
$11.16
52-wk Low
$3.75

Latest Key Developments (Source: Significant Developments)

Viveve Medical Inc files for mixed shelf of up to $50 million
Wednesday, 8 Nov 2017 05:17pm EST 

Nov 8 (Reuters) - Viveve Medical Inc :Viveve Medical Inc files for mixed shelf of up to $50 million .  Full Article

Viveve reports Q3 loss per share $0.50
Wednesday, 8 Nov 2017 04:02pm EST 

Nov 8 (Reuters) - Viveve Medical Inc :Viveve announces third quarter 2017 financial results.Q3 loss per share $0.50.Q3 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S.Q3 revenue $4.1 million versus i/b/e/s view $3.7 million.  Full Article

Viveve releases preliminary Q3 2017 financial results
Wednesday, 18 Oct 2017 08:28am EDT 

Oct 18 (Reuters) - Viveve Medical Inc :Viveve releases preliminary third quarter 2017 financial results.Viveve Medical- sees Q3 revenue from sale of 60 Viveve systems, about 2,700 disposable treatment tips, ancillary consumables to be about $4.1 million​‍​.  Full Article

Viveve gets regulatory nod to market Viveve System in Mexico
Tuesday, 17 Oct 2017 08:28am EDT 

Oct 17 (Reuters) - Viveve Medical Inc :Viveve announces regulatory approval for Viveve System in Mexico.Viveve Medical - received approval from Mexican regulatory authority, COFEPRIS, to market Viveve System in Mexico for treatment of vaginal introitus​.Viveve Medical Inc - working to submit IDE to FDA to conduct pivotal study on use of Viveve System for improvement in sexual function in women​.  Full Article

Viveve announces regulatory approval for Viveve System in Taiwan
Tuesday, 10 Oct 2017 08:28am EDT 

Oct 10 (Reuters) - Viveve Medical Inc :Viveve announces regulatory approval for Viveve System in Taiwan.Viveve Medical - got approval to market Viveve System from Taiwanese FDA for use in general surgical procedures for electrocoagulation,hemostasis​.Viveve - In process of submitting investigational device exemption to U.S FDA to conduct study on use of device for improvement in sexual function in women​.  Full Article

Viveve announces additional regulatory approvals in Middle East
Tuesday, 12 Sep 2017 08:28am EDT 

Sept 12 (Reuters) - Viveve Medical Inc :Viveve announces additional regulatory approvals in Middle East.Viveve Medical Inc - ‍has received regulatory approvals for Viveve system in Bahrain, Kuwait, and Qatar​.  Full Article

Viveve Medical reports Q2 loss per share $0.54
Thursday, 10 Aug 2017 04:01pm EDT 

Aug 10 (Reuters) - Viveve Medical Inc -:Viveve announces second quarter 2017 financial results and strategic partnership with Incontrol Medical, Llc.Q2 loss per share $0.54.Q2 earnings per share view $-0.43 -- Thomson Reuters I/B/E/S.Q2 revenue $3.1 million versus i/b/e/s view $3.2 million.Viveve Medical Inc - entered into an exclusive distribution agreement and strategic investment with Incontrol Medical, Llc.Viveve Medical Inc - exclusive distribution agreement to treat various incontinence conditions and strengthen pelvic floor muscles.  Full Article

Viveve Q1 loss per share $0.57
Thursday, 11 May 2017 04:02pm EDT 

May 11 (Reuters) - Viveve Medical Inc ::Viveve reports first quarter 2017 financial results.Q1 loss per share $0.57.Q1 earnings per share view $-0.51 -- Thomson Reuters I/B/E/S.Says recognized approximately $3 million in total revenue for q1 of 2017, representing 24% growth over q4 2016.Q1 revenue view $2.6 million -- Thomson Reuters I/B/E/S.  Full Article

Viveve says expanded indication for Viveve System in South Korea
Tuesday, 9 May 2017 08:28am EDT 

May 9 (Reuters) - Viveve Medical Inc ::Viveve announces expanded indication for Viveve System in South Korea.Under terms of expanded indication, Viveve system will now also be indicated for treatment of vaginal laxity in South Korea.Received regulatory approval for an expanded indication for Viveve System from ministry of food and drug safety in South Korea.  Full Article

Viveve Medical says U.S. District court for eastern district of Texas denied motions to dismiss Viveve patent infringement suit
Tuesday, 25 Apr 2017 08:28am EDT 

April 25 (Reuters) - Viveve Medical Inc ::Viveve Medical Inc says u.s. District court for eastern district of Texas has denied motions to dismiss Viveve patent infringement suit.  Full Article

BRIEF-Viveve Medical Inc files for mixed shelf of up to $50 million

* Viveve Medical Inc files for mixed shelf of up to $50 million Source text: (http://bit.ly/2zIf6EQ) Further company coverage: